Overview

Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The study will assess safety and tolerability of different doses of topical gel containing a new chemical entity, NVN1000, and the vehicle (gel without drug) applied to the face of healthy volunteers with high counts of Propionibacterium acnes. The test product will be applied once daily for 4 weeks. Exploratory measures include whether the topical product decreases the amount of a bacteria associated with acne (P. acnes).
Phase:
Phase 1
Details
Lead Sponsor:
Novan, Inc.